Back
77
Day Range
$34.21
$36.00
52-Week Range
$11.26
$46.67
Volume
632,511
50D / 200D Avg
$37.72
/
$27.42
Prev Close
$35.50
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -45.0 | 0.4 |
| P/B | 69.3 | 2.9 |
| ROE % | -113.0 | 3.7 |
| Net Margin % | -43.5 | 3.9 |
| Rev Growth 5Y % | 87.3 | 10.0 |
| D/E | 4.4 | 0.2 |
Analyst Price Target
Hold
$50.67
+43.9%
Low: $47.00
High: $55.00
Forward P/E
14.7
Forward EPS
$2.41
EPS Growth (est.)
+0.0%
Est. Revenue
590 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$6.12
$3.60 – $8.34
|
1.4 B | 2 |
| FY2029 |
$5.66
$3.33 – $7.71
|
1.2 B | 4 |
| FY2028 |
$5.09
$0.44 – $8.94
|
1.1 B | 6 |
Key Takeaways
Revenue grew 87.34% annually over 5 years — strong growth
Debt/Equity of 4.42 — high leverage
Negative free cash flow of -40.02M
PEG of 0.83 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 943.84%
Capital efficient — spends only 2.74% of revenue on capex
Growth
Revenue Growth (5Y)
87.34%
Revenue (1Y)1031.18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-112.97%
ROIC-15.88%
Net Margin-43.53%
Op. Margin-32.45%
Safety
Debt / Equity
4.42
Current Ratio1.40
Interest Coverage-2.13
Valuation
P/E Ratio
-45.00
P/B Ratio69.31
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1031.18% | Revenue Growth (3Y) | 200.88% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 87.34% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 158.32M | Net Income (TTM) | -68.92M |
| ROE | -112.97% | ROA | -21.02% |
| Gross Margin | 97.21% | Operating Margin | -32.45% |
| Net Margin | -43.53% | Free Cash Flow (TTM) | -40.02M |
| ROIC | -15.88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 4.42 | Current Ratio | 1.40 |
| Interest Coverage | -2.13 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -45.00 | P/B Ratio | 69.31 |
| P/S Ratio | 19.59 | PEG Ratio | 0.83 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 3.10B | Enterprise Value | 3.11B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 158.32M | 14.00M | 17.49M | 15.94M | 12.85M |
| Net Income | -68.92M | -130.39M | -78.50M | -41.02M | -34.58M |
| EPS (Diluted) | -0.80 | -1.66 | -1.21 | -0.67 | -0.70 |
| Gross Profit | 153.90M | 8.12M | 14.60M | 13.08M | 9.83M |
| Operating Income | -51.38M | -121.29M | -73.38M | -38.77M | -33.80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 327.93M | 230.31M | 118.33M | 129.20M | 93.73M |
| Total Liabilities | 283.19M | 153.04M | 71.04M | 38.78M | 28.46M |
| Shareholders' Equity | 44.75M | 77.28M | 47.29M | 90.42M | 65.27M |
| Total Debt | 197.93M | 122.39M | 49.54M | 24.46M | 16.08M |
| Cash & Equivalents | 190.68M | 176.48M | 83.68M | 93.28M | 57.49M |
| Current Assets | 190.68M | 185.11M | 89.90M | 99.81M | 61.28M |
| Current Liabilities | 135.77M | 41.78M | 18.55M | 8.80M | 7.33M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#6 of 147
Recent Activity
Entered
Full Throttle
Mar 24, 2026